Subscribe to Newsletter
Fields & Applications Pharma & Biopharma, Translational Science, Spectroscopy

How siRNA Mixing Shapes Gene Therapy Success

Credit: Adobe Stock

A nuclear magnetic resonance (NMR)-guided approach has revealed how different methods of mixing small interfering RNA (siRNA) with lipid nanoparticles (LNPs) can significantly impact their molecular structure and gene-silencing efficiency. The findings offer a deeper understanding of how the internal structure of LNPs influences their therapeutic effectiveness and could lead to more effective gene therapies and RNA-based medicines.

“NMR allowed us to peer inside these nanoparticles at a molecular level, revealing the intricate details of how siRNA is distributed within the LNP core. This level of insight is crucial for understanding and optimizing LNP formulations,” said lead author Keisuke Ueda, assistant professor at Chiba University, in a press release.

The study compared three different methods for incorporating siRNA into LNPs: pre-mixing, where siRNA and lipids are combined early in the process; and two post-mixing methods, where siRNA is added to pre-formed LNPs, either with or without ethanol. All methods produced nanoparticles of a similar size (approximately 50 nm), but the internal distribution of siRNA within the LNPs varied significantly depending on the method used.

According to the study, pre-mixed LNPs exhibited a more uniform distribution of siRNA, whereas post-mixed LNPs showed regions of both high and low siRNA concentration, leading to heterogeneity. "This heterogeneity can significantly impact the silencing effect of the siRNA. LNPs with a more uniform siRNA distribution are more likely to deliver their therapeutic payload to target cells effectively," explained Ueda in the press release.

In addition to solution-state ¹H NMR, the team also used small-angle X-ray scattering (SAXS) and cryogenic transmission electron microscopy (cryo-TEM) to further analyze the internal structure of the LNPs. SAXS data indicated that pre-mixed LNPs formed a tightly packed, stacked bilayer structure where ionizable lipids were closely associated with siRNA, enhancing the nanoparticles’ ability to silence genes. In contrast, post-mixed LNPs showed a more disordered structure, which could reduce their ability to fuse with cell membranes and deliver siRNA to target cells. These findings were corroborated by gene-silencing tests, which showed that pre-mixed LNPs outperformed post-mixed LNPs.

“These findings could improve people’s lives by enhancing gene therapies and RNA-based medicines,” Dr. Ueda added. “By optimizing how siRNA is delivered using lipid nanoparticles, treatments for diseases like cancer, genetic disorders, and viral infections could become more effective.”

NEWS

The Analytical Scientist Presents:

The Analytical Scientist Weekly Newsletter

Enjoying our content? Join a growing community of like-minded individuals with the hottest topics at your fingertips, specially curated by our Editorial team.

Register for our weekly newsletter

Receive content, products, events as well as relevant industry updates from The Analytical Scientist and its sponsors.
Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

Related Application Notes
Charge variant analysis of antibody-drug conjugates using an icIEF-UV/MS workflow

| Contributed by SCIEX

High recoveries from IEX analysis of mAbs with the first injection – no preconditioning required!

| Contributed by YMC

Analysis of PEGylated Antibody Fragments using SEC-MALS

| Contributed by Tosoh

Related Product Profiles
Higher Peaks – Clearly.

| Contributed by Shimadzu Europa

Compact with countless benefits

| Contributed by Shimadzu Europa

The fine Art of Method Development

| Contributed by Shimadzu Europa

Register to The Analytical Scientist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Analytical Scientist magazine

Register